The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. - Wikidata - wikimedia - TriplyDB

The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

http://www.wikidata.org/entity/Q37198894

about

Neuroimaging biomarkers of neurodegenerative diseases and dementia Prediction of cognitive decline in healthy older adults using fMRI Validation of the Face Name Associative Memory Exam in cognitively normal older individuals The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adults Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk Comparison of semantic and episodic memory BOLD fMRI activation in predicting cognitive decline in older adults Machine learning amplifies the effect of parental family history of Alzheimer's disease on list learning strategy Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.Brain imaging of neurovascular dysfunction in Alzheimer's disease.Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.Advances in functional magnetic resonance imaging: technology and clinical applications.Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.Cognitive activities and cognitive performance in middle-aged adults at risk for Alzheimer's disease.Atorvastatin therapy is associated with greater and faster cerebral hemodynamic response Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques.Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention Midlife predictors of Alzheimer's disease.White matter in aging and cognition: a cross-sectional study of microstructure in adults aged eighteen to eighty-three.Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline.White matter is altered with parental family history of Alzheimer's disease Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers.NSAIDs may protect against age-related brain atrophy.Family history and APOE-4 genetic risk in Alzheimer's disease.Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population.Functional alterations in memory networks in early Alzheimer's disease.Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.Family history of Alzheimer's disease and hippocampal structure in healthy people.Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.Increased fMRI signal with age in familial Alzheimer's disease mutation carriers.Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.

P2860

Q27691820-4E1A80F7-0E9C-4560-AF48-BBB88CDF84DE Q28383378-78DC5DAA-44A4-48D7-8816-51F1614841D6 Q28386196-FB340052-B072-42DF-AABB-7D1F953F698C Q28386834-098F1C68-CF48-40A4-9391-2E86FEF42B07 Q28394313-E7BE4DEA-A29C-4848-BF36-F5E9B25B7447 Q28394799-7696EE4A-4AE5-4728-87DA-8824E4F515F7 Q28394980-0E1E8CE9-4FAA-4392-8240-D543550F5E02 Q30455024-3BE94B68-D30B-4B1F-AA4E-E3085FEDEA5B Q30498720-37A62F0C-BCE1-47FC-90A5-79BFF9F2A602 Q30870223-A571EC73-D339-405B-97AA-BC2576D22398 Q30890481-F9AA1408-2B63-4928-8133-A232C49E213B Q31066988-9C1B73C3-1E5F-4BBD-812F-339DE1D5308D Q31111440-05B0CA73-FA71-42FC-A8CC-2F2C7E46700B Q31117150-693B92B8-2A2A-41E7-B39B-D9292817BCF0 Q33601299-FEBA17C9-3540-490D-BC6C-FEAE05C46F5A Q33643289-AFE6EBFA-F057-46D2-BDE1-BBE29964A457 Q33649943-8AB6C244-AA8D-481C-B62E-5CB83A0452E8 Q33721909-06832BE1-1B6C-4F84-B64B-9F2F5410AC81 Q33741447-9D10AED1-B511-4549-B9FE-F2DE8C46B231 Q33773031-A3AABAAB-5283-44A1-9184-7E72569AB38F Q33778436-ACDD9B81-B0D9-4AA1-93B8-D4D9E89D468B Q33875000-8812FBB8-E08C-4212-AB94-D2EFE6EF1ADA Q33922707-87ADF832-3B12-4F0D-B389-EBF924F03690 Q33956934-C7508693-76FF-459C-9B1E-ECB8055EAD10 Q33956998-5DAAB177-CB7D-4FCA-9A7A-3886FD41CBAC Q34002796-D5825A63-C617-440C-8226-4F4AD667454A Q34103755-1429D3CE-2608-4001-9D3C-951F5C7AE104 Q34145373-6602BB60-5F67-42A3-9F28-2A0888671AC0 Q34146458-C9C3E53E-833C-49E2-89D0-CA85F37C6953 Q34151315-0F979424-AE35-4F9D-B0EB-9D010D80114E Q34167647-EE0B4FC7-A651-48E1-AF1C-3991229CFD53 Q34561059-EE013E38-039B-483C-AF63-603944EF09F5 Q34565270-F2EF8917-E6E7-469C-81B6-AC92E44A84B7 Q34647037-57804808-9998-4063-AF0B-B1D908EEC48B Q34691589-FE6FB7E0-2440-4EC1-96CC-679645BD686B Q34907217-1DBACD01-7F61-4811-BCB4-FDC88FFE11EB Q34984743-E2E7E0A8-8EEE-4B5A-B88F-278703E9119C Q34990172-46DE20F1-7C0C-4151-A8E2-45512D3366FF Q35119064-F4303E03-AED5-4FA8-BCD0-5489BC03C167 Q35127361-9BC711FE-5A6E-492C-85C2-DFEAC3D025DB

P2860

The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

http://www.wikidata.org/entity/Q37198894

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The influence of Alzheimer dis ...... sial temporal lobe activation.

@en

The influence of Alzheimer dis ...... sial temporal lobe activation.

@nl

type

label

The influence of Alzheimer dis ...... sial temporal lobe activation.

@en

The influence of Alzheimer dis ...... sial temporal lobe activation.

@nl

prefLabel

The influence of Alzheimer dis ...... sial temporal lobe activation.

@en

The influence of Alzheimer dis ...... sial temporal lobe activation.

@nl

P1433

Q37198894-8A53517D-00D2-42FB-921A-36904FE0590A

P1476

Q37198894-56396B6A-DE17-4336-A743-A0F35F2049E0

P2093

Q37198894-14CC9447-4413-4166-9869-B7A0FDAC8DC0

Q37198894-152E43C2-01D0-47AF-8130-4BDFC252BD6D

Q37198894-61377D8B-8957-42B3-B31D-1FA5553235EC

Q37198894-829BC110-A743-4E8C-B223-FAF0D2941E21

Q37198894-93B98C03-F933-407B-8620-91AA2D4E4AF7

Q37198894-9D3AF94C-73AE-40B3-8BD7-3319E8CD0BF5

Q37198894-A6EBE04F-5289-4F14-BC5D-4324AB7AEFD2

Q37198894-BD065E59-8277-48B2-A7E7-8BD6907BE8A9

Q37198894-DDF87335-64C2-4C2A-8276-D39E524D4C10

P2860

Q37198894-03A370B8-E7BB-4762-ADCF-677BE0C5B19B

Q37198894-05BEBAE7-EAA4-4A80-AD98-67D297565982

Q37198894-06528D9C-BF80-45C8-8CAE-FBBF73BBD993

Q37198894-073246BE-6DC8-4A70-943B-2DBD7D1E0BE4

Q37198894-0BEF681A-F5B7-49C2-97B4-F898B0DDE174

Q37198894-14BD40AF-BBDB-4E8E-9AD1-501862054C3A

Q37198894-15732572-D212-4D6A-B033-34F20FB08444

Q37198894-1E40AB58-CD70-40B0-8D60-79A4E896D2B0

Q37198894-1F19287B-5D46-460E-850E-AF061DCA9462

Q37198894-1F4E7265-DBF9-4B70-8B15-1629C0930E2E

P304

Q37198894-F919B023-95FB-44F9-9A6F-99B189D846F3

P31

Q37198894-84B2CF3A-F998-4A42-ABAE-ECB8981732CA

P356

Q37198894-E4F5C3D8-D418-4D3F-B4AE-3859EE5D0E0D

P407

Q37198894-62F30E24-3EB6-43E5-AA04-40236B51913A

P433

Q37198894-58089F0C-AA49-4D0B-ADBE-20CBF305A605

P478

Q37198894-37A05DC8-B9DC-42FD-9EC3-0FEFE5D5EB9E

P577

Q37198894-C0ABB06E-4030-4B41-8FBE-F044C0B0EF79

P698

Q37198894-EA02752C-3CF6-4CB8-B615-8D644EF4EE12

P921

Q37198894-E2802F49-E23B-4CA2-ADF7-3F779BFBCFF6

P932

Q37198894-A91960F6-7663-423A-AAB9-2D7C4A9216D6

P356

JNEUROSCI.0959-06.2006

P1433

Journal of Neuroscience

P1476

The influence of Alzheimer dis ...... sial temporal lobe activation.

@en

P2093

Britta M Torgerson

http://www.w3.org/2001/XMLSchema#string

Bruce P Hermann

http://www.w3.org/2001/XMLSchema#string

Cynthia M Carlsson

http://www.w3.org/2001/XMLSchema#string

Mark A Sager

http://www.w3.org/2001/XMLSchema#string

Mehul A Trivedi

http://www.w3.org/2001/XMLSchema#string

Michele L Ries

http://www.w3.org/2001/XMLSchema#string

Sanjay Asthana

http://www.w3.org/2001/XMLSchema#string

Sterling C Johnson

http://www.w3.org/2001/XMLSchema#string

Taylor W Schmitz

http://www.w3.org/2001/XMLSchema#string

P2860

When zero is not zero: the problem of ambiguous baseline conditions in fMRI

WHAT DOES fMRI TELL US ABOUT NEURONAL ACTIVITY?

APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians

Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

A voxel-based morphometric study of ageing in 465 normal adult human brains

Family-based association between Alzheimer's disease and variants in UBQLN1

Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

P304

6069-6076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.0959-06.2006

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16738250

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2684824

http://www.w3.org/2001/XMLSchema#string